Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 11:18 AM 2012  
0688 BLK BK BEN TROW AMP 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for HSP and BPTH ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Hospira Inc.  and   Biopath Holdings Inc
Check Correlation Matrix  
Daily Returns (%)
BPTH  HSP  
Timeline
Considering 30-days investment horizon, Hospira Inc. is expected to under-perform the Biopath. But the stock apears to be less risky and, when comparing its historical volatility, Hospira Inc. is 6.28 times less risky than Biopath. The stock trades about -0.26 of its potential returns per unit of risk. The Biopath Holdings Inc is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 29.00 in Biopath Holdings Inc on April 26, 2012 and sell it today you would earn a total of 8.00 from holding Biopath Holdings Inc or generate 27.59% return on investment over 30 days.

Diversification

Weak diversification
Overlapping area represents amount of risk that can be diversified away by holding Hospira Inc. and Biopath Holdings Inc in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.38
 Parameters
Time Period1 Month [change]
DirectionPositive BPTH.OB Moved Up vs HSP
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between HSP and BPTH with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between HSP and BPTH to your reader
 
Get social with Correlation between HSP and BPTH
 Share Correlation between HSP and BPTH 
Share Share Correlation between HSP and BPTH
    
    
 
       
Predicted Return Density
Expected Daily Returns   
BPTH  HSP  

Hospira Inc.

 
    
    
Hospira
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Hospira Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Valeant Pharmaceuticals International Inc. vs. Hospira Inc.
Elan Corporation plc vs. Hospira Inc.
Alkermes Inc. vs. Hospira Inc.
PetMed Express Inc. vs. Hospira Inc.
Acura Pharmaceuticals Inc. vs. Hospira Inc.
Flamel Technologies SA vs. Hospira Inc.
  

Biopath Holdings Inc

 
    
    
Biopath
Performance
9
Out Of
100
Over 30
Days
91% of all equities and portfolios perform better than Biopath Holdings Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Biopath Holdings Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 30 days.
    
    
Valeant Pharmaceuticals International Inc. vs. Biopath Holdings Inc
Elan Corporation plc vs. Biopath Holdings Inc
Hospira Inc. vs. Biopath Holdings Inc
Alkermes Inc. vs. Biopath Holdings Inc
PetMed Express Inc. vs. Biopath Holdings Inc
Acura Pharmaceuticals Inc. vs. Biopath Holdings Inc
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting